Female gender is also known to increase the penetrance of BMPR2 mutations in HPAH.3 Reasons for these gender differences remain unclear, however, there is converging evidence suggesting that sex hormones, in particular oestrogens, are a major risk factor in females with PAH and play a pivotal role in PAH pathogenesis. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.